Prediction of ovarian reserve based on day-3 serum follicle stimulating hormone concentrations during the pituitary suppression cycle using a gonadotropin releasing hormone agonist in patients undergoing in vitro fertilization-embryo transfer

By Onagawa T   Shibahara H     Machida S   Hirano Y   Hirashima C   Takamizawa S   Suzuki M  

Gynecological Endocrinology, Vol. 18, Iss. 6, 2004-06 ,pp. : 335-340

Informa Healthcare

Access to resources Recommend Favorite

Endocrinology. The value of basal serum follicle stimulating hormone, luteinizing hormone and oestradiol concentrations following pituitary down-regulation in predicting ovarian response to stimulation with highly purified follicle stimulating hormone*

By Develioglu O.H.   Cox B.   Toner J.P.   Oehninger S.  

Human Reproduction, Vol. 14, Iss. 5, 1999-05 ,pp. : 1168-1174

Oxford University Press

Access to resources Recommend Favorite

The onset of the initial rise in follicle-stimulating hormone during the human menstrual cycle

By Miro F.   Aspinall L.J.  

Human Reproduction, Vol. 20, Iss. 1, 2005-01 ,pp. : 96-100

Oxford University Press

Access to resources Recommend Favorite

Immunoneutralization of follicle stimulating hormone does not affect gonadotrophin surge-inhibiting factor/attenuating factor bioactivity during the rat ovarian cycle

By Tio S   van Dieten JAMJ   de Koning J  

Human Reproduction, Vol. 13, Iss. 10, 1998-10 ,pp. : 2731-2737

Oxford University Press

Access to resources Recommend Favorite

Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon)

By Mitchell R.  

Human Reproduction, Vol. 11, Iss. 5, 1996-05 ,pp. : 962-967

Oxford University Press

Access to resources Recommend Favorite